Experienced in Panhypopituitarism

Dr. Michael Gottschalk

Pediatric Endocrinology
Rady Children's Hospital San Diego
3020 Childrens Way, 
San Diego, CA 
Experienced in Panhypopituitarism
Rady Children's Hospital San Diego
3020 Childrens Way, 
San Diego, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Gottschalk is a Pediatric Endocrinologist in San Diego, California. Dr. Gottschalk is rated as an Experienced provider by MediFind in the treatment of Panhypopituitarism. His top areas of expertise are Type 1 Diabetes (T1D), Type A Insulin Resistance Syndrome, Acanthosis Nigricans, and Precocious Puberty.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Endocrinology
Licenses
Pediatric Endocrinology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 10 Less Insurance Carriers -

Locations

Rady Children's Hospital San Diego
3020 Childrens Way, San Diego, CA 92123
Call: 858-576-1700
Other Locations
Office
3030 Childrens Way, San Diego, CA 92123
Call: 858-966-4032

Additional Areas of Focus

Dr. Gottschalk has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both
Enrollment Status: Completed
Publish Date: September 26, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Post-operative Methylprednisolone Taper Course for Orthopedic Surgery
Post-operative Methylprednisolone Taper Course for Orthopedic Surgery
Enrollment Status: Enrolling_by_invitation
Publish Date: February 25, 2025
Intervention Type: Drug, Other
Study Drugs: Dexamethasone, Methylprednisolone
Study Phase: Phase 4
A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity
A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity
Enrollment Status: Completed
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drugs: LUM-201, rhGH Norditropin® pen
Study Phase: Phase 2
Corticosteroid(CS) Injections for the Treatment of Common Upper Extremity Pathologies, With or Without Lidocaine
Corticosteroid(CS) Injections for the Treatment of Common Upper Extremity Pathologies, With or Without Lidocaine
Enrollment Status: Terminated
Publish Date: October 12, 2022
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drug: Dulaglutide
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 7 Less Clinical Trials

20 Total Publications

Correlation Between Technology and Improved Outcomes in Youth With Type 1 Diabetes Mellitus: Prospective Study Examining Outcomes for Patients With Depression and Those With Public Insurance.
Correlation Between Technology and Improved Outcomes in Youth With Type 1 Diabetes Mellitus: Prospective Study Examining Outcomes for Patients With Depression and Those With Public Insurance.
Journal: JMIR diabetes
Published: December 20, 2024
View All 20 Publications
Similar Doctors
Experienced in Panhypopituitarism
Dr. Mary Patterson
Pediatric Endocrinology
Experienced in Panhypopituitarism
Dr. Mary Patterson
Pediatric Endocrinology

Rady Children's Hospital San Diego

3020 Childrens Way, 
San Diego, CA 
 (0.1 miles away)
858-966-4032
Languages Spoken:
English
See accepted insurances

Mary Patterson is a Pediatric Endocrinologist in San Diego, California. Dr. Patterson is rated as an Experienced provider by MediFind in the treatment of Panhypopituitarism. Her top areas of expertise are Short Stature (Growth Disorders), Familial Short Stature (FSS), Idiopathic Short Stature (ISS), and Precocious Puberty.

Experienced in Panhypopituitarism
Dr. Karen Oerter
Pediatric Endocrinology
Experienced in Panhypopituitarism
Dr. Karen Oerter
Pediatric Endocrinology

Rady Children's Hospital San Diego

3020 Childrens Way, 
San Diego, CA 
 (0.1 miles away)
858-966-4032
Languages Spoken:
English
See accepted insurances

Karen Oerter is a Pediatric Endocrinologist in San Diego, California. Dr. Oerter is rated as a Distinguished provider by MediFind in the treatment of Panhypopituitarism. Her top areas of expertise are Precocious Puberty, Turner Syndrome, Intersex, Mixed Gonadal Dysgenesis, and Hormone Replacement Therapy (HRT).

Experienced in Panhypopituitarism
Dr. Carla Demeterco
Pediatric Endocrinology
Experienced in Panhypopituitarism
Dr. Carla Demeterco
Pediatric Endocrinology

Rady Children's Hospital San Diego

3020 Childrens Way, 
San Diego, CA 
 (0.1 miles away)
858-966-4032
Languages Spoken:
English
See accepted insurances

Carla Demeterco is a Pediatric Endocrinologist in San Diego, California. Dr. Demeterco is rated as an Advanced provider by MediFind in the treatment of Panhypopituitarism. Her top areas of expertise are Diabetic Ketoacidosis, Type 1 Diabetes (T1D), Short Stature (Growth Disorders), and Precocious Puberty.

VIEW MORE PANHYPOPITUITARISM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gottschalk's expertise for a condition
ConditionClose
      • Advanced
      • Acanthosis Nigricans
        Dr. Gottschalk is
        Advanced
        . Learn about Acanthosis Nigricans.
        See more Acanthosis Nigricans experts
      • Type 1 Diabetes (T1D)
        Dr. Gottschalk is
        Advanced
        . Learn about Type 1 Diabetes (T1D).
        See more Type 1 Diabetes (T1D) experts
      • Type A Insulin Resistance Syndrome
        Dr. Gottschalk is
        Advanced
        . Learn about Type A Insulin Resistance Syndrome.
        See more Type A Insulin Resistance Syndrome experts
      • Experienced
      • Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)
        Dr. Gottschalk is
        Experienced
        . Learn about Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED).
        See more Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) experts
      • Autoimmune Polyglandular Syndrome Type 2
        Dr. Gottschalk is
        Experienced
        . Learn about Autoimmune Polyglandular Syndrome Type 2.
        See more Autoimmune Polyglandular Syndrome Type 2 experts
      • Congenital Hyperinsulinism
        Dr. Gottschalk is
        Experienced
        . Learn about Congenital Hyperinsulinism.
        See more Congenital Hyperinsulinism experts
      • Congenital Hypothyroidism
        Dr. Gottschalk is
        Experienced
        . Learn about Congenital Hypothyroidism.
        See more Congenital Hypothyroidism experts
      • Diabetes Insipidus (DI)
        Dr. Gottschalk is
        Experienced
        . Learn about Diabetes Insipidus (DI).
        See more Diabetes Insipidus (DI) experts
      • Diabetic Ketoacidosis
        Dr. Gottschalk is
        Experienced
        . Learn about Diabetic Ketoacidosis.
        See more Diabetic Ketoacidosis experts
      View All 29 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.